We previously constructed an immortal human hepatocyte line NKNT-3 with a simian virus 40 T antigen (SV40T) to develop cell-based biological therapies. p21 is a molecule that regulates the transition from the G 1 phase to the S phase of the cell cycle. Investigators have demonstrated that overexpression of p21 induces differentiation in various cell lines. In the current study we examined the effect of p21 on differentiated phenotypes of SV40T-immortalized NKNT-3 cells. A replication-deficient adenovirus vector expressing a human wild-type p21 cDNA under the control of the CMV promoter (Ad5CMVp21) and a human wild-type p21 protein fused to the protein transduction domain from the human immunodeficiency virus (HIV) TAT protein (TAT/p21) were utilized to achieve efficient delivery of p21 into NKNT-3 cells. Morphological alterations, cell cycle progression, and expression of albumin and p-450 associated enzymes (CYPs) 3A4 and 2C9 were evaluated in NKNT-3 cells treated with Ad5CMVp21 and TAT/p21. Efficient adenovirusbased p21 transfer and TAT-mediated p21 protein delivery were confirmed in NKNT-3 cells in an immunofluorescence study and Western blotting analysis. Transduction of NKNT-3 cells with p21 predominantly arrested the cell cycle at the G 1 checkpoint, resulting in differentiated hepatic phenotypes in morphology and improvement in protein expression of albumin, CYP 3A4, and CYP C29. We here show that exogenous expression of p21 augments cellular differentiation in immortalized human NKNT-3 cells.
INTRODUCTION
therapies such as hepatocyte transplantation and a bioartificial liver. Previously we reported the establishment of an immortalized human hepatocyte cell line, NKNT-3, Expression of a sdi1 gene, which encodes a 21-kDa protein product, is enhanced in senescent cells compared using a retroviral vector expressing a loxP-flanked simian virus 40 large T antigen (SV40T) gene that was sub-with their young counterparts and its increase parallels the onset of the senescent phenotype (14) . Subsequently, sequently removable by Cre/loxP site-specific recombination (9) . It is of great value to increase differentiated p21 sdi1 has been cloned as a gene encoding a cyclindependent kinase (Cdk) inhibitor (Cip1) (6) , and as a hepatic phenotypes of NKNT-3 cells for cell therapies. Toward this purpose, we have focused on the use of a molecule transcriptionally activated by p53 (Waf1) (1) . p21 was also cloned as a melanocyte differentiation-Cdk inhibitor p21 to enhance differentiation of NKNT-3 cells. Because an adenoviral gene delivery has reported associated factor activated independent of p53 (mda-6) (7) . These findings concerning p21 have elucidated the to be highly efficient, first we utilize an adenovirus vector expressing a human wild-type p21 cDNA to trans-potent interactions of cell cycle regulation and cell differentiation.
duce NKNT-3 cells (2, 8) .
On the other hand, cellular manipulation by viral We have made great efforts to construct human liver cell lines for the development of cell-based biological introduction of cDNA expression vectors has presented some difficulties, including broad cell-to-cell intra-made use of MOI 10 in the Ad5CMVp21 transduction experiment. NKNT-3 cells were transduced with cellular concentration ranges of expressed proteins and immune response against viral structural proteins. The Ad5CMVp21, and 48 h later total cell lysates were obtained from Ad5CMVp21-infected cells with a cell lysis ability to manipulate cellular processes by the introduction of full-length proteins in a concentration-dependent buffer, resolved on 12% SDS-PAGE, and transferred onto nitrocellulose membranes (Amersham, Japan), as fashion into 100% of cells would be desirable. Although proteins cannot pass through the plasma membrane of previously reported (15). Samples were reacted with a mouse monoclonal antibody against human p21 (1:100) cells, a protein fused to the Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg peptide from the human immuno-(Santa Crutz Biotechnology, Santa Cruz, CA) followed by a horseradish-peroxidase-conjugated anti-mouse IgG deficiency virus (HIV) TAT protein, which has the protein transduction domain (PTD), can efficiently enter the secondary antibody (1:2000) (MBL, Nagoya, Japan). Human β-actin protein served as an internal control. Hu-cell membrane and be incorporated into cells (3, 4) . Transduction of TAT fusion protein occurs without bind-man p21 and human β-actin were then detected by means of an enhanced chemiluminescence system (ECL ing to receptors targeting the lipid bilayer component of the cell membrane (17) . In addition, the TAT fusion pro-detection kit, Amersham). tein has an interesting feature in that it is able to move Construction and Purification of pTAT-GST into the nucleus by the embedded nuclear localization (Glutathione-S-Transferease) and pTAT/p21 signal in the TAT PTD. Thus, in the current work we Expression Vectors examine this alternative approach of TAT-mediated p21
pTAT-GST and pTAT-p21 vectors were constructed protein transduction to elicit cell differentiation of imby inserting the PCR fragments encompassing the open mortalized human NKNT-3 cells.
reading frames of GST from S. japonicum and the hu-MATERIALS AND METHODS man wild-type p21 into XhoI and EcoRI sites of a Cells and Culture Conditions pTAT-HA prokaryote expression vector, respectively, as reported previously (16) . The vector pTAT-HA has an Human hepatocytes were transduced with a retroviral N-terminal 6-histidine (His) leader followed by the 11vector SSR#69 encoding SV40T, as previously reported amino-acid TAT PTD flanked by glycine residues for (9). One of the resulting clones, NKNT-3, looked epithefree bond rotation of the domain. The nucleotide selial and displayed morphological characteristics of liver quences of the expression vectors were confirmed by parenchymal cells. NKNT-3 cells were maintained with DNA sequencing (Model 491 peptide sequencer, Apthe chemically defined serum-free CS-C medium (Cell plied Biosystems, Foster, CA). TAT fusion proteins Systems Co., Seattle, WA). The cell cultures were carewere purified as previously described (13, 16) . fully examined by means of an inverted phase contrast microscope.
Cytotoxicity Associated With TAT/p21 Protein Transduction A Recombinant Adenovirus Expressing p21
One million NKNT-3 cells were plated on a well of A recombinant adenovirus vector encoding a human six-well plates. Twenty-four hours later 1, 5, 10, 25, and wild-type p21 cDNA, Ad5CMVp21 (kindly provided by 50 µg/ml of a TAT/p21 fusion protein were added into Dr. J. A. Roth, University of Texas M.D. Anderson Canthe culture medium and cell cultures were maintained cer Center, Houston, TX), was previously constructed for 24 h. Then cells were treated with 20 µg of substrate and characterized in detail (2, 8) . An adenoviral vector 5-diphenyl-2H tetrazolium bromide (MTT) to evaluate expressing an E. coli LacZ gene (Ad5CMVLacZ, also TAT/p21-induced cytotoxicity in NKNT-3 cells. Cells kindly provided by Dr. J. A. Roth) with the same CMV were incubated for 4 h at 37°C, reacted with 1 ml iso-(human cytomegalovirus) promoter of Ad5CMVp21 propanol for 10 min, and were eventually examined for was used as a control in the present p21 transduction MTT uptake with a phase contrast microscope. experiment. The viral stocks were quantified by a plaqueforming assay with 293 cells and then stored at −80°C.
Transduction of NKNT-3 Cells With TAT/p21 Infection of NKNT-3 Cells With Ad5CMVp21
Transduction efficiency of TAT/p21 was examined to detect 6-His in NKNT-3 cells. Cells were treated NKNT-3 cells were treated with various MOIs of Ad5CMVLacZ to examine transduction efficiency and with TAT/p21 (1, 5, and 10 µg/ml), and 3 h later total cell lysates were obtained with a cell lysis buffer, as adenovirus-induced cytotoxicity. In Ad5CMVLacZ infection of MOIs ≥5, NKNT-3 cells uniformly expressed described above. Protein samples of 30 µg/ml were subjected to Western blotting analysis using a mouse anti-LacZ under X-gal staining and no cytotoxic effects were observed based on our previous study (10) . We His antibody (Amersham Pharmacia, Bromma, Sweden).
Immunofluorescence Study for p21 Expression cells were inoculated on coverslips placed on a well of six-well plates and 24 h later treated with Ad5CMVp21 To detect the localization of p21 transduced, an im-(MOI 10) or TAT/p21 (5 µg/ml). Forty-eight hours after munofluorescent study was performed. A mouse mono-Ad5CMVp21 infection or 24 h after TAT/p21 transducclonal IgG antibody to human p21 (1:100) and a FITCtion, cells were prepared to visualize albumin expression conjugated sheep polyclonal antibody to mouse IgG (1: with the same procedure described in the immunofluo-2000) (Sigma, St. Louis, MO) were used for indirect rescent analysis for p21. Transduction of NKNT-3 cells immunofluorescent staining. NKNT-3 cells were inocuwith Ad5CMVLacZ or TAT/GST was performed as a lated on coverslips placed on a well of six-well plates control experiment. and subjected to Ad5CMVp21 infection at MOI 10 and TAT/p21 (5 µg/ml) transduction. Forty-eight hours after
Western Blotting Analysis for CYP 3A4 and CYP 2C9 Ad5CMVp21 infection or 24 h after TAT/p21 transduction, cells were fixed with 4% paraformaldehyde in Forty-eight hours after infection with Ad5CMVp21 phosphate-buffered saline (PBS) for 30 min at room (MOI 10), total cell lysates were prepared from NKNT-3 temperature (RT). Free aldehyde groups were quenched cells, as described above. As a control, NKNT-3 cells with 50 mM in PBS for 10 min. The samples were were infected with Ad5CMVLacZ (MOI 10). Protein washed three times with PBS at RT and permeabilized samples (30 µg/ml) were treated with a mouse monowith cold 100% ethanol for 30 min at 4°C. After three clonal antibody against human CYP 3A4 and CYP 2C9 washes with PBS, cells were incubated in blocking solu-(Daiichi Pure Chemicals. Inc. Ltd., Tokyo, Japan) (1: tion (10% skim milk, 10% FBS, 0.1% sodium azide, and 100) followed by a horseradish-peroxidase-conjugated 0.1% Triton X-100 in PBS) for 30 min at RT. The samanti-mouse IgG secondary antibody (1:2000) (MBL, Naples were treated with mouse monoclonal anti-p21 IgG goya, Japan). NKNT-3 cells were transduced with TAT/ in the blocking solution for 1 h at 37°C. After washing p21 (5 µg/ml) for 24 h and 30 µg/ml of protein samples the samples three times with the blocking solution, cells were also subjected to CYP 3A4 and CYP 2C9 experiwere treated for 1 h at 37°C with the secondary antiments. NKNT-3 cells were treated with TAT/GST in a body. The samples were washed three times with the control study. Protein expression of human β-actin was blocking solution and the coverslips were mounted onto used to verify the equal loading of the samples. slides with Vectashield Mounting Medium (Vector Laboratories, Burlingame, CA) for observation. A fluores-RESULTS cence microscope (Model Axiophot FL, Carl Zeiss, Inc., Morphology Oberkochen, Germany) was used to visualize the localization of p21.
After infection of NKNT-3 cells with Ad5CMVp21 (MOI 10), morphological changes in cells were carefully Cell Cycle Analysis of NKNT-3 Cells After examined with phase contrast microscopy. Decreased p21 Transduction cell density and enlargement of the size with a lower To examine the cell cycle, NKNT-3 cells were subnuclear-to-cytoplasmic (N/C) ratio occurred in jected to flow cytometric analysis 48 h after infection Ad5CMVp21-infected NKNT-3 cells. Similar morphowith Ad5CMVp21 or 24 h after TAT/p21 (5 and 10 µg/ logical alterations were observed in NKNT-3 cells transml) transduction. Cells were trypsinized, washed twice duced with 5 µg/ml TAT/p21 (Fig. 1 ). These findings with cold PBS, and resuspended in PBS containing 0.1%
were not detected in a control AdCMVLacZ or TAT/ Triton X-100 and 0.1% RNase for 5 min at RT. The GST experiment. samples were then stained with propidium iodide (0.1 mg/ml), filtered through a 40-µM pore size nylon mesh, Cytotoxicity Associated With TAT/p21 and analyzed in a cell sorter (FACScan, Becton Dickin-Protein Transduction son, Mountain View, CA) for DNA content. Cell debris
We examined TAT/p21-induced cytotoxicity in and fixation artifacts were gated out, and G 0 /G 1 , S, and NKNT-3 cells treated with various concentrations of G 2 -M populations were quantified with the ModFit LT TAT/p21 fusion protein. NKNT-3 cells showed normal program for Macintosh (version 1.01; Verity Software uptake of MTT when treated with TAT/p21 of 1-10 µg/ House, Inc.). As a control, NKNT-3 cells were treated ml, indicating that cells were actively alive (Fig. 2) . In with AdCMVLacZ or TAT/GST. contrast, cells transduced with ≥25 µg/ml TAT/p21 were Immunofluorescence Study for Albumin Expression negative for MTT uptake, showing that cells were severely damaged (Fig. 2) . A high dose (≥25 ⁄g/ml) of A FITC-conjugated rabbit polyclonal IgG antibody to human albumin (1:100) (DAKO, Tokyo, Japan) was used TAT/p21 transduction induced considerable adverse effects in NKNT-3 cells ( Fig. 2E, F) . for an immunofluorescence study for albumin. NKNT-3 
Detection of Exogenous p21 Expression in NKNT-3
cells 48 h after AdCMVp21 infection at MOI 10. As shown in Figure 4 , bands for p21 were detected in Cells Treated With TAT/p21
Ad5CMVp21-infected cells. An immunofluorescent Because TAT/p21 fusion protein had PTD and 6-His, staining showed nuclear localization of adenovirally deuptake of TAT/p21 by NKNT-3 cells was detected by livered p21 in NKNT-3 cells (Fig. 4) . Similar results Western blot analysis using a mouse anti-His antibody.
were obtained in NKNT-3 cells with TAT/p21 (5 µg/ Intensity of the band indicating existence of exogeml) transduction. These findings were not detected in a nously delivered TAT/p21 increased in a dose-depencontrol AdCMVLacZ or TAT/GST transduction. dent fashion, as shown in Figure 3 . These findings indicated the efficient p21 delivery into NKNT-3 cells by Cell Cycle Analysis means of TAT-mediated protein transduction.
After infection with Ad5CMVp21, NKNT-3 cells
Expression of p21 Protein and its Localization
were arrested in the G 0 /G 1 phase, but this did not occur in AdCMVLacZ transduction. Marked G 0 /G 1 arrest was Western blotting analysis and immunofluorescent study for p21 expression were carried out in NKNT-3 also observed in NKNT-3 cells treated with TAT/p21 of not observed in a control Ad5CMVLacZ or TAT/GST experiment.
Expression of CYP 3A4 and CYP 2C9
To evaluate protein expression of CYP 3A4 and CYP 2C9, 30 µg of proteins from AdCMVp21-transduced NKNT-3 cells was subjected to Western blotting analysis. As shown in Figure 7 , more intense bands for CYP tion for various types of diseases. Normal human cells These findings were consistent with the differentiated are ideal for such therapies, but their use is severely limmorphological alterations in NKNT-3 cells with p21 ited by donor organ and tissue shortage for human cell transduction (Fig. 1) .
isolation, difficulties of long-term culture, and loss of Albumin Expression After p21 Transduction differentiated phenotypes after several passages. An attractive alternative would be the establishment of human After p21 transduction, albumin expression was evaluated in an immunofluorescent study. Expression of al-cell lines. Previously we engineered human hepatocytic cell line NKNT-3. Such cell lines allow the rapid prepa-bumin was very weak or almost absent in unmodified NKNT-3 cells (Fig. 6A) . p21 transduction increased al-ration of uniform cells when needed, but, on the other hand, cells would lose differentiated functions to some bumin expression of NKNT-3 cells (Fig. 6B ), which was degree. Thus, it is of extreme importance to elicit differ-of cancer and in-born metabolic disorders, and to facilitate cell therapies, conditions for high-efficiency target-entiation in such cells.
A CDK inhibitor p21, known as sdi1, Cip1, WAF1, ing and long-term protein expression have yet to be discovered. Currently, PTD-linked peptides and proteins or mda-6, has been originally identified as a molecule that regulates the transition from the G 1 phase to the S can be transduced into cells simply by adding them to tissue culture medium (3,4,17). Thus, we evaluated an phase of the cell cycle (1, 6, 7, 14) . During skeletal muscle differentiation, the muscle-specific transcriptional regu-attractive approach of TAT-mediated p21 protein transduction in NKNT-3 cells. TAT/p21 fusion protein was lator MyoD increases p21 expression, thereby inducing terminal cell cycle arrest (5) . In addition, it has been efficiently internalized in NKNT-3 cells in a concentration-dependent manner when used in a range of 1-25 reported that p21 expression is more frequently detected in well-differentiated non-small cell lung carcinoma µg/ml. TAT-mediated transduction could provide several advantages over DNA transfection, the current stan-than in poorly differential tumors (12). Overexpression of p21 has been shown to induce differentiation in mono-dard method of intracellular protein expression. First, most eukaryotic cell types are susceptible to transduc-blastic cell lines (11) . Together, these observations suggest that p21 is involved in a terminal differentiation tion, excluding yeast. Second, as transduction occurs so rapidly (15 min rather than 12 h in serum-free medium program in normal as well as cancer cells.
The effect of p21 on immortalized hepatocytes, for transfection), issues of timing can be overcome. Third, the exact intracellular concentration can be con-however, has not been well documented. In the present study, we first examined an adenoviral delivery of trolled precisely just by varying the amount added to the culture medium. Furthermore, every cell in the popula-p21 in NKNT-3 cells. Transduction of NKNT-3 with Ad5CMVp21 at MOI 10 improved differentiated hepatic tion appears to contain a near-identical intracellular protein level. Potential immune responses and cytotoxicity phenotypes of cells. Although gene therapy is one promising method to treat diseases, including various types associated with long-term transduction of proteins in vivo are important issues to be addressed. This form of methodology would open new possibilities for the development of vaccines, cancer treatment, and cell-based biological therapies. In summary, our results demonstrate that introduction of p21 into human immortalized hepatocytes can increase albumin, CYP 3A4, and CYP 2C9 expression and induce differentiated phenotypes. These findings may facilitate the utility of p21 transduction in various cell lines for clinical applications.
